Vanda Pharmaceuticals, Inc. is a pharmaceutical company based in the United States that focuses on developing and commercializing therapies to meet medical needs. With an ESG score of 24.8, they are categorized as a medium-risk company. Their commercial portfolio includes products like HETLIOZ, Fanapt, and PONVORY. Vanda Pharmaceuticals aims to improve patients' lives through innovative healthcare solutions.